@bewellbykelly
1 post audited · 6 claims analysed
Science evidence grade
Based on 6 claims across 1 audit
4
Supported
67%
0
Overstated
0%
0
Misleading
0%
2
No Evidence
33%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @bewellbykelly claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
67%
4 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
33%
2 claims
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(1 post)
“Episode 306: The Truth About GLP-1 Peptides: Benefits, Myths & Misconceptions with Dr. Tyna Moore 🎙️Comment: PEPTIDES for the episode. Meet Dr. Tyna Moore, a seasoned naturopathic physician and chiropractor, renowned for her expertise in holistic regenerative medicine and metabolic health. You may recognize Dr. Moore from her viral content on microdosing GLP-1. I was intrigued by the scientific perspective she shares on GLP-1 and GLP-1 agonists, especially given that many of our previously used peptides are no longer available - #I knew I had to have her on the podcast! In this episode, we delve deep into the science behind these peptides. Dr. Tyna demonstrates that under professional care and with the right dosage and comprehensive health plan, they can be an incredible tool for longevity and healing. In this episode, we explore: + What an GLP-1 agonist is + The science behind conventional doses vs. micro-dosing + Exposing how critical the right dose is for maximizing benefits and minimizing side effects + How the peptides in medications like Ozempic, Wegovy, and Manjaro compare to those naturally produced by our bodies I love to hear a multitude of perspectives on topics like this from all sides, and I promise you don’t want to miss this one! 👉 Comment PEPTIDES and I’ll send you the episode to start listening now… *Please note: Always consult with your healthcare provider to understand the best treatment plan for you and to manage any potential side effects.”
Of six claims, only one (GLP-1 impact on appetite) is directly supported by robust clinical evidence and FDA approval data. The remaining five claims—brain anti-inflammation, neuroregeneration, dopamine effects, serotonin effects, and systemic anti-inflammation—lack peer-reviewed literature or human clinical trial data demonstrating these specific effects for GLP-1 peptides. While conceptual plausibility exists for several (GLP-1 receptors are expressed in brain; GLP-1 has anti-inflammatory activity in other contexts), the leap from plausibility to claimed effect is not yet bridged by indexed scientific evidence. No studies were cited by the creator, limiting ability to verify specific claims against primary sources.
Audit another post from @bewellbykelly
Paste their Instagram link to add a new audit